HEADER TRANSCRIPTION 10-FEB-17 5N49 TITLE BRPF2 IN COMPLEX WITH COMPOUND 7 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BR140-LIKE PROTEIN,BROMODOMAIN AND PHD FINGER-CONTAINING COMPND 5 PROTEIN 2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD1, BRL, BRPF2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS BROMODOMAIN, CHEMICAL PROBE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR L.BOUCHE,C.D.CHRIST,S.SIEGEL,A.E.FERNANDEZ-MONTALVAN,S.J.HOLTON, AUTHOR 2 O.FEDOROV,A.TER LAAK,T.SUGAWARA,D.STOECKIGT,C.TALLANT,J.BENNETT, AUTHOR 3 O.MONTEIRO,L.D.SAEZ,P.SIEJKA,J.MEIER,V.PUETTER,J.WEISKE,S.MUELLER, AUTHOR 4 K.V.M.HUBER,I.V.HARTUNG,B.HAENDLER REVDAT 3 24-MAY-17 5N49 1 JRNL REVDAT 2 10-MAY-17 5N49 1 JRNL REVDAT 1 03-MAY-17 5N49 0 JRNL AUTH L.BOUCHE,C.D.CHRIST,S.SIEGEL,A.E.FERNANDEZ-MONTALVAN, JRNL AUTH 2 S.J.HOLTON,O.FEDOROV,A.TER LAAK,T.SUGAWARA,D.STOCKIGT, JRNL AUTH 3 C.TALLANT,J.BENNETT,O.MONTEIRO,L.DIAZ-SAEZ,P.SIEJKA,J.MEIER, JRNL AUTH 4 V.PUTTER,J.WEISKE,S.MULLER,K.V.M.HUBER,I.V.HARTUNG, JRNL AUTH 5 B.HAENDLER JRNL TITL BENZOISOQUINOLINEDIONES AS POTENT AND SELECTIVE INHIBITORS JRNL TITL 2 OF BRPF2 AND TAF1/TAF1L BROMODOMAINS. JRNL REF J. MED. CHEM. V. 60 4002 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28402630 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00306 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 32821 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1728 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.74 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.78 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2232 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.90 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 118 REMARK 3 BIN FREE R VALUE : 0.3770 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1932 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 343 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.29000 REMARK 3 B22 (A**2) : -0.07000 REMARK 3 B33 (A**2) : -0.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.100 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.108 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.452 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.933 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1994 ; 0.024 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1936 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2691 ; 2.134 ; 1.992 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4401 ; 1.117 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 234 ; 5.513 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;35.963 ;23.084 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 367 ;13.841 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;13.613 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 292 ; 0.135 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2241 ; 0.013 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 470 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 942 ; 2.349 ; 2.250 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 941 ; 2.351 ; 2.244 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1174 ; 3.157 ; 3.350 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1175 ; 3.156 ; 3.357 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1052 ; 3.368 ; 2.653 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1050 ; 3.371 ; 2.654 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1515 ; 5.252 ; 3.819 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2689 ; 6.915 ;19.713 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2491 ; 6.704 ;18.681 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 554 A 675 REMARK 3 ORIGIN FOR THE GROUP (A): -13.4730 10.7100 4.9800 REMARK 3 T TENSOR REMARK 3 T11: 0.0066 T22: 0.0511 REMARK 3 T33: 0.0376 T12: 0.0096 REMARK 3 T13: 0.0049 T23: -0.0117 REMARK 3 L TENSOR REMARK 3 L11: 0.5819 L22: 0.0497 REMARK 3 L33: 0.9337 L12: -0.0600 REMARK 3 L13: -0.5919 L23: 0.1017 REMARK 3 S TENSOR REMARK 3 S11: -0.0048 S12: -0.0011 S13: -0.0026 REMARK 3 S21: 0.0141 S22: 0.0317 S23: -0.0104 REMARK 3 S31: 0.0229 S32: 0.0107 S33: -0.0269 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 559 B 701 REMARK 3 ORIGIN FOR THE GROUP (A): -13.0050 -11.8100 19.2620 REMARK 3 T TENSOR REMARK 3 T11: 0.0845 T22: 0.0988 REMARK 3 T33: 0.0429 T12: 0.0314 REMARK 3 T13: 0.0149 T23: -0.0024 REMARK 3 L TENSOR REMARK 3 L11: 0.3671 L22: 0.1191 REMARK 3 L33: 0.5420 L12: 0.1986 REMARK 3 L13: -0.4388 L23: -0.2492 REMARK 3 S TENSOR REMARK 3 S11: -0.0847 S12: -0.0277 S13: -0.0535 REMARK 3 S21: -0.0389 S22: 0.0130 S23: -0.0319 REMARK 3 S31: 0.0967 S32: 0.0048 S33: 0.0717 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5N49 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1200003506. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUL-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918409 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34549 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 38.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.50400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS PH 6.5, 30% (W/V) PEG REMARK 280 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.27800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.17000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.49150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.17000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.27800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.49150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 676 REMARK 465 GLU A 677 REMARK 465 ALA A 678 REMARK 465 SER A 679 REMARK 465 GLY A 680 REMARK 465 MET A 681 REMARK 465 HIS A 682 REMARK 465 LEU A 683 REMARK 465 PRO A 684 REMARK 465 GLU A 685 REMARK 465 ARG A 686 REMARK 465 PRO A 687 REMARK 465 ALA A 688 REMARK 465 SER B 554 REMARK 465 MET B 555 REMARK 465 GLU B 556 REMARK 465 GLN B 557 REMARK 465 VAL B 558 REMARK 465 ILE B 673 REMARK 465 GLY B 674 REMARK 465 LEU B 675 REMARK 465 GLU B 676 REMARK 465 GLU B 677 REMARK 465 ALA B 678 REMARK 465 SER B 679 REMARK 465 GLY B 680 REMARK 465 MET B 681 REMARK 465 HIS B 682 REMARK 465 LEU B 683 REMARK 465 PRO B 684 REMARK 465 GLU B 685 REMARK 465 ARG B 686 REMARK 465 PRO B 687 REMARK 465 ALA B 688 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET B 560 CG SD CE REMARK 470 GLU B 561 CG CD OE1 OE2 REMARK 470 ARG B 563 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 617 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 847 O HOH A 869 4455 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 556 CG GLU A 556 CD 0.095 REMARK 500 GLU A 556 CD GLU A 556 OE2 0.080 REMARK 500 GLU A 561 CD GLU A 561 OE2 -0.085 REMARK 500 GLU A 628 CD GLU A 628 OE2 0.077 REMARK 500 ASP A 657 CB ASP A 657 CG 0.135 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 617 OE1 - CD - OE2 ANGL. DEV. = -7.7 DEGREES REMARK 500 ASP A 632 CB - CG - OD1 ANGL. DEV. = 8.7 DEGREES REMARK 500 ARG A 644 NE - CZ - NH1 ANGL. DEV. = 8.4 DEGREES REMARK 500 ARG A 644 NE - CZ - NH2 ANGL. DEV. = -7.8 DEGREES REMARK 500 ASP A 657 CB - CG - OD1 ANGL. DEV. = 8.2 DEGREES REMARK 500 ARG A 664 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 668 CD - NE - CZ ANGL. DEV. = 8.6 DEGREES REMARK 500 ARG A 668 NE - CZ - NH1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG A 668 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 LEU A 675 CB - CG - CD1 ANGL. DEV. = 13.5 DEGREES REMARK 500 LEU A 675 N - CA - C ANGL. DEV. = -17.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 645 -7.09 81.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 916 DISTANCE = 7.00 ANGSTROMS REMARK 525 HOH B 925 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH B 926 DISTANCE = 6.35 ANGSTROMS REMARK 525 HOH B 927 DISTANCE = 6.39 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8LW B 701 DBREF 5N49 A 555 688 UNP O95696 BRD1_HUMAN 555 688 DBREF 5N49 B 555 688 UNP O95696 BRD1_HUMAN 555 688 SEQADV 5N49 SER A 554 UNP O95696 EXPRESSION TAG SEQADV 5N49 MET A 555 UNP O95696 VAL 555 CONFLICT SEQADV 5N49 GLU A 566 UNP O95696 PRO 566 CONFLICT SEQADV 5N49 ARG A 569 UNP O95696 VAL 569 CONFLICT SEQADV 5N49 SER B 554 UNP O95696 EXPRESSION TAG SEQADV 5N49 MET B 555 UNP O95696 VAL 555 CONFLICT SEQADV 5N49 GLU B 566 UNP O95696 PRO 566 CONFLICT SEQADV 5N49 ARG B 569 UNP O95696 VAL 569 CONFLICT SEQRES 1 A 135 SER MET GLU GLN VAL ALA MET GLU LEU ARG LEU THR GLU SEQRES 2 A 135 LEU THR ARG LEU LEU ARG SER VAL LEU ASP GLN LEU GLN SEQRES 3 A 135 ASP LYS ASP PRO ALA ARG ILE PHE ALA GLN PRO VAL SER SEQRES 4 A 135 LEU LYS GLU VAL PRO ASP TYR LEU ASP HIS ILE LYS HIS SEQRES 5 A 135 PRO MET ASP PHE ALA THR MET ARG LYS ARG LEU GLU ALA SEQRES 6 A 135 GLN GLY TYR LYS ASN LEU HIS GLU PHE GLU GLU ASP PHE SEQRES 7 A 135 ASP LEU ILE ILE ASP ASN CYS MET LYS TYR ASN ALA ARG SEQRES 8 A 135 ASP THR VAL PHE TYR ARG ALA ALA VAL ARG LEU ARG ASP SEQRES 9 A 135 GLN GLY GLY VAL VAL LEU ARG GLN ALA ARG ARG GLU VAL SEQRES 10 A 135 ASP SER ILE GLY LEU GLU GLU ALA SER GLY MET HIS LEU SEQRES 11 A 135 PRO GLU ARG PRO ALA SEQRES 1 B 135 SER MET GLU GLN VAL ALA MET GLU LEU ARG LEU THR GLU SEQRES 2 B 135 LEU THR ARG LEU LEU ARG SER VAL LEU ASP GLN LEU GLN SEQRES 3 B 135 ASP LYS ASP PRO ALA ARG ILE PHE ALA GLN PRO VAL SER SEQRES 4 B 135 LEU LYS GLU VAL PRO ASP TYR LEU ASP HIS ILE LYS HIS SEQRES 5 B 135 PRO MET ASP PHE ALA THR MET ARG LYS ARG LEU GLU ALA SEQRES 6 B 135 GLN GLY TYR LYS ASN LEU HIS GLU PHE GLU GLU ASP PHE SEQRES 7 B 135 ASP LEU ILE ILE ASP ASN CYS MET LYS TYR ASN ALA ARG SEQRES 8 B 135 ASP THR VAL PHE TYR ARG ALA ALA VAL ARG LEU ARG ASP SEQRES 9 B 135 GLN GLY GLY VAL VAL LEU ARG GLN ALA ARG ARG GLU VAL SEQRES 10 B 135 ASP SER ILE GLY LEU GLU GLU ALA SER GLY MET HIS LEU SEQRES 11 B 135 PRO GLU ARG PRO ALA HET 8LW B 701 28 HETNAM 8LW 2-(1,3,6-TRIMETHYL-2-OXIDANYLIDENE-BENZIMIDAZOL-5-YL) HETNAM 2 8LW BENZO[DE]ISOQUINOLINE-1,3-DIONE FORMUL 3 8LW C22 H17 N3 O3 FORMUL 4 HOH *343(H2 O) HELIX 1 AA1 SER A 554 LYS A 581 1 28 HELIX 2 AA2 ASP A 598 ILE A 603 1 6 HELIX 3 AA3 ASP A 608 ALA A 618 1 11 HELIX 4 AA4 ASN A 623 ASN A 642 1 20 HELIX 5 AA5 THR A 646 GLY A 674 1 29 HELIX 6 AA6 MET B 560 ASP B 580 1 21 HELIX 7 AA7 ASP B 598 ILE B 603 1 6 HELIX 8 AA8 ASP B 608 ALA B 618 1 11 HELIX 9 AA9 ASN B 623 ASN B 642 1 20 HELIX 10 AB1 THR B 646 SER B 672 1 27 SITE 1 AC1 13 LEU A 562 ASP A 645 THR A 646 ALA B 584 SITE 2 AC1 13 ILE B 586 GLN B 589 VAL B 591 SER B 592 SITE 3 AC1 13 TYR B 641 ASN B 642 PHE B 648 HOH B 810 SITE 4 AC1 13 HOH B 816 CRYST1 56.556 56.983 102.340 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017682 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017549 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009771 0.00000